Zobrazeno 1 - 10
of 87
pro vyhledávání: '"J M Vossen"'
Autor:
Carel G. M. Meskers, Sabina van der Veen, Jenia Kim, Caroline J. W. Meskers, Quirine T. S. Smit, Stella Verkijk, Edwin Geleijn, Guy A. M. Widdershoven, Piek T. J. M. Vossen, Marike van der Leeden
Publikováno v:
Annals of Medicine, Vol 54, Iss 1, Pp 235-243 (2022)
Purpose To address the feasibility, reliability and internal validity of natural language processing (NLP) for automated functional assessment of hospitalised COVID-19 patients in key International Classification of Functioning, Disability and Health
Externí odkaz:
https://doaj.org/article/f63bd2e6745749869696d06b220c8d41
Autor:
Jan A.M. Langermans, Pieter S. Hiemstra, A. M. Matze-Van Der Lans, R. Van Furth, A. J. De Beaufort, J. M. Vossen
Publikováno v:
Scandinavian Journal of Immunology. 46:597-600
The binding and opsonic properties of C-reactive protein (CRP) for various species of bacteria were investigated. CRP bound more avidly to killed than to live Streptococcus pneumoniae, the binding varying among various serotypes; CRP hardly bound to
Autor:
J Henwood, M C van Eggermond, A H van Boxel-Dezaire, R Schipper, M den Hoedt, A Peijnenburg, O Sanal, F Ersoy, G T Rijkers, B J Zegers, J M Vossen, M J van Tol, P J van den Elsen
Publikováno v:
The Journal of Immunology. 156:895-906
In this study, we have investigated the impact of deficient MHC class II expression on the use of TCRBV6 and TCRBJ gene elements, and on the pattern of amino acid incorporation exhibited in the N1-D-N2 segments of the third complementarity-determinin
Publikováno v:
The Journal of Immunology. 151:6451-6459
Lethally irradiated C3H/Law mice were injected (i.v.) with C57BL/Rij allogeneic bone marrow cells to induce a delayed type graft-vs-host disease (GVHD). Signs of GVHD first became apparent in the third week after transplantation. The disease resulted
Autor:
E J, Gerritsen, M J, van Tol, A C, Lankester, C P, van der Weijden-Ragas, C M, Jol-van der Zijde, N J, Oudeman-Gruber, J, Radl, J M, Vossen
Publikováno v:
Blood. 82:3493-3502
Bone marrow graft recipients suffer profound immunodeficiency during at least 3 months after transplantation. B-cell reconstitution following allogeneic bone marrow transplantation (BMT) in children was studied longitudinally by quantification of Ig
Publikováno v:
Blood. 82:1921-1928
We performed polymerase chain reaction-variable number of tandem repeats analysis of flow-sorted peripheral blood T-, B-, natural killer- , and myeloid cell populations (van Leeuwen et al, Br J Haematol 79:218, 1991) in 32 children following allogene
Autor:
T W, Kuijpers, J M, Vossen
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 144(37)
The advances of molecular biological techniques of the last decade have made possible identification of a rapidly increasing number of congenital (or primary) immune deficiencies at the genetic level. As soon as an immune deficiency is becoming a lik
Autor:
J M, Vossen, T W, Kuijpers
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 144(31)
Severe congenital immunodeficiency diseases occur in approximately 1:10,000 newborns, in Western Europe and North America. They are characterised by recurrent infections, mostly caused by opportunistic micro-organisms, and autoimmune phenomena. In ma
Autor:
A, Peijnenburg, M J, Van Eggermond, S J, Gobin, R, Van den Berg, B C, Godthelp, J M, Vossen, P J, Van den Elsen
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 163(2)
MHC class II deficiency or bare lymphocyte syndrome is a severe combined immunodeficiency caused by defects in MHC-specific transcription factors. In the present study, we show that fibroblasts derived from a recently identified bare lymphocyte syndr
Autor:
B C, Godthelp, M C, van Eggermond, A, Peijnenburg, I, Tezcan, S, van Lierde, M J, van Tol, J M, Vossen, P J, van den Elsen
Publikováno v:
Blood. 94(1)
To study the effects of major histocompatibility complex (MHC) class II expression on T-cell development, we have investigated T-cell immune reconstitution in two MHC class II-deficiency patients after allogeneic bone marrow transplantation (allo-BMT